Informações:
Falhas:
ID
14099
Descrição
Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression; ODM derived from: https://clinicaltrials.gov/show/NCT00177528
Link
https://clinicaltrials.gov/show/NCT00177528
Palavras-chave
Versões (1)
- 29/03/2016 29/03/2016 -
Transferido a
29 de março de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Depression NCT00177528
Eligibility Depression NCT00177528
- StudyEvent: Eligibility
Similar models
Eligibility Depression NCT00177528
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Gender, ethnic groups and age
Item
men and women of all races who are 60 years old or older;
boolean
C0079399 (UMLS CUI [1])
C0015031 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
C0015031 (UMLS CUI [2])
C0001779 (UMLS CUI [3])
DSM-IV diagnosis of major depressive episode
Item
a dsm-iv diagnosis of major depressive episode without psychotic features;
boolean
C2199206 (UMLS CUI [1])
Hamilton Rating Scale for Depression
Item
17-item ham-d score of >15 for potential subjects who have not received any antidepressant treatment during this illness episode or ham-d > 11 for potential subjects who have received treatment with an antidepressant (other than venlafaxine-xr) during this illness episode;
boolean
C0451203 (UMLS CUI [1])
Mini-mental state examination
Item
a mmse score of >15.
boolean
C0451306 (UMLS CUI [1])
Mental status
Item
history of meeting dsm-iv criteria for mania, schizophrenia or other psychotic disorder;
boolean
C0024713 (UMLS CUI [1])
C0036341 (UMLS CUI [2])
C0033975 (UMLS CUI [3])
C0036341 (UMLS CUI [2])
C0033975 (UMLS CUI [3])
Substance abuse disorder
Item
history of substance abuse or dependence, including alcohol, within the last three months;
boolean
C0038586 (UMLS CUI [1])
Serum sodium measurement
Item
current hyponatremia (as defined as a serum sodium level < 130 meq/l);
boolean
C0523891 (UMLS CUI [1])
Hypertension
Item
untreated or uncontrolled hypertension;
boolean
C0020538 (UMLS CUI [1])
Venlafaxine allergy
Item
a history of being unable to tolerate venlafaxine-xr or venlafaxine immediate release formulation;
boolean
C0570764 (UMLS CUI [1])
Venlafaxine therapy and ECG
Item
history of receiving venlafaxine-xr or venlafaxine immediate release formulation of 6 or more weeks at 300mg/d during index depressive episode; (7) ekg revealing qtc > 480 msec;
boolean
C0078569 (UMLS CUI [1])
C0489625 (UMLS CUI [2])
C0489625 (UMLS CUI [2])
Cardiovascular status
Item
myocardial infarction, unstable angina, palpitation or cardiogenic syncope within 3 months prior to entering this study;
boolean
C0027051 (UMLS CUI [1])
C0002965 (UMLS CUI [2])
C0030252 (UMLS CUI [3])
C0751535 (UMLS CUI [4])
C0002965 (UMLS CUI [2])
C0030252 (UMLS CUI [3])
C0751535 (UMLS CUI [4])
Suicide risk
Item
the presence of active suicidal ideation with intent.
boolean
C1271074 (UMLS CUI [1])